This summer, the work of Italian researchers and laboratories published in international scientific journals mostly centered on the fields of oncology, genetics and neuroscience. Monitoring of the scientific press (including Science, The Lancet and the various journals of the Nature group) revealed that 84 studies conducted by Italian laboratories were published between the beginning of July and the end of September. As in previous monitoring periods, a high proportion of the works published were in the field of oncology, with 25 studies appearing in the pages of Leukemia, Oncogene, The Lancet Oncology, the British Journal of Cancer, Cell Death & Disease, and Modern Pathology, involving the work of 233 researchers across 29 Italian research centers.
Italian research efforts in the area of genetics also gained international exposure, with 5 studies published over the summer period in journals such as Science, the European Journal of Human Genetics and Gene Therapy (with a total of 86 researchers and 23 research centers involved). Other papers (5 studies undertaken by 41 researchers in 15 centers) concerned work in the field of neuroscience, and were picked up by Scientific Report, Neuropsychopharmacology and Cell Death & Disease.
Finally, Italian contributions to nanotechnology are the subject of an interview with Francesco Stellacci carried on Aspen Italia’s website. A member of the Institute’s “Italian talent abroad” group, as well as being professor of Materials Engineering at EPFL in Lausanne and co-founder of the start-up company Molecular Stamping, Stellacci talked to the Aspen website team about how to successfully transfer skills across from the research sphere to industry.
ARTICLES MONITORED: 84
ITALIAN RESEARCHERS: 664
ITALIAN RESEARCH CENTERS: 163